South Wales, April 6 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "ENDOCRIQ" on March 19. The details about the trademark application no. UK00004358021 published in the journal no. 2026/014 (April 3).
With Forresters IP LLP as representative, TOXIQUA LTD filed the trademark application for the below mentioned good(s)/service(s).
Class 42 : Scientific risk assessment services; scientific and technological consultancy; testing of chemicals; testing of pharmaceuticals; environmental testing; toxicology and toxicity analysis; neurotoxin analysis of chemicals; endocrine analysis of chemicals; carcinogenicity analysis of chemicals; toxicology research services; toxicology testing for medical, research, chemical and forensic purposes; toxicology for assessing the risks of chemicals, agrochemicals, pharmaceuticals, pollutants, and other substances to human health and the environment; toxicity analysis; toxicity testing for medical, research, chemical and forensic purposes; scientific research and software development services relating to endocrine disruption assessment; IT, computer, computer programming, and software, AI and machine learning software development services relating to endocrine disruption assessment; software-as-a-service (SaaS) and platform-as-a-service (PaaS) relating to endocrine disruption assessment; IT, computer, computer programming, and software, AI and machine learning software development services relating to modelling hormonal signalling disruption caused by chemical substances; software-as-a-service (SaaS) and platform-as-a-service (PaaS) relating to modelling hormonal signalling disruption caused by chemical substances; provision of computational toxicology platforms for chemical safety evaluation and regulatory toxicology analysis; IT, computer, computer programming, and software, AI and machine learning software development services relating to chemical safety evaluation and regulatory toxicology analysis; software-as-a-service (SaaS) and platform-as-a-service (PaaS) relating to chemical safety evaluation and regulatory toxicology analysis; information, consultancy and advisory services relating to the aforesaid.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004358021
Disclaimer: Curated by HT Syndication.
